{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T05:56:50Z","timestamp":1759730210637,"version":"3.37.3"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biometals"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s10534-022-00409-1","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T17:02:51Z","timestamp":1656522171000},"page":"491-507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effect of bovine lactoferrin on recurrent urinary tract infections: in vitro and in vivo evidences"],"prefix":"10.1007","volume":"36","author":[{"given":"Antonietta Lucia","family":"Conte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catia","family":"Longhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Pia","family":"Conte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Costanzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalba","family":"Paesano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Santangeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Venditto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Tripepi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Naldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuditta","family":"Pollio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Cavallini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Marrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Faltoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piera","family":"Valenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1252-6080","authenticated-orcid":false,"given":"Luigi","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"409_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1139\/o01-211","volume":"80","author":"M Ajello","year":"2002","unstructured":"Ajello M, Greco R, Giansanti F, Massucci MT, Antonini G, Valenti P (2002) Anti-invasive activity of bovine lactoferrin towards group A streptococci. Biochem Cell Biol 80:119\u2013124. https:\/\/doi.org\/10.1139\/o01-211","journal-title":"Biochem Cell Biol"},{"key":"409_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.12816\/0003256","volume":"13","author":"A Al-Badr","year":"2013","unstructured":"Al-Badr A, Al-Shaikh G (2013) Recurrent urinary tract infections management in women: a review. Sultan Qaboos Univ Med J 13:359\u2013367","journal-title":"Sultan Qaboos Univ Med J"},{"key":"409_CR3","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/j.1699-0463.1997.tb05071.x","volume":"105","author":"KR Alugupalli","year":"1997","unstructured":"Alugupalli KR, Kalfas S (1997) Characterization of the lactoferrin-dependent inhibition of the adhesion of Actinobacilllus Actinomycetemcomitans, Prevotella Intermedia and Prevotella Nigrescens to fibroblasts and to a reconstituted basement membrane. APMIS 105:680\u2013688. https:\/\/doi.org\/10.1111\/j.1699-0463.1997.tb05071.x","journal-title":"APMIS"},{"issue":"3","key":"409_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4315\/0362-028X-60.3.267","volume":"60","author":"G Antonini","year":"1997","unstructured":"Antonini G, Catania MR, Greco R, Longhi C, Pisciotta MG, Seganti L, Valenti P (1997) Anti-invasive activity of bovine lactoferrin against listeria monocytogenes. J Food Prot 60(3):267\u2013271. https:\/\/doi.org\/10.4315\/0362-028X-60.3.267","journal-title":"J Food Prot"},{"issue":"6","key":"409_CR5","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1128\/iai.62.6.2628-2632.1994","volume":"62","author":"BJ Appelmelk","year":"1994","unstructured":"Appelmelk BJ, An YQ, Geerts M, Thijs BG, de Boer HA, MacLaren DM, de Graaff J, Nuijens JH (1994) Lactoferrin is a lipid A-binding protein. Infect Immun 62(6):2628\u20132632. https:\/\/doi.org\/10.1128\/iai.62.6.2628-2632.1994","journal-title":"Infect Immun"},{"issue":"3","key":"409_CR6","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1128\/JCM.37.3.553-557.1999","volume":"37","author":"S Arao","year":"1999","unstructured":"Arao S, Matsuura S, Nonomura M, Miki K, Kabasawa K, Nakanishi H (1999) Measurement of urinary lactoferrin as a marker of urinary tract infection. J Clin Microbiol 37(3):553\u2013557. https:\/\/doi.org\/10.1128\/JCM.37.3.553-557.1999","journal-title":"J Clin Microbiol"},{"key":"409_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1023\/b:biom.0000027710.13543.3f","volume":"17","author":"K Ashida","year":"2004","unstructured":"Ashida K, Sasaki H, Sasaki YA, Lo\u00f6nnerdal B (2004) Cellular internalization of lactoferrin in intestinal epithelial cells. Biometals 17:311\u2013315. https:\/\/doi.org\/10.1023\/b:biom.0000027710.13543.3f","journal-title":"Biometals"},{"issue":"5","key":"409_CR8","doi-asserted-by":"publisher","first-page":"F814","DOI":"10.1152\/ajprenal.00133.2018","volume":"316","author":"KA Bauckman","year":"2019","unstructured":"Bauckman KA, Matsuda R, Higgins CB, DeBosch BJ, Wang C, Mysorekar IU (2019) Dietary restriction of iron availability attenuates UPEC pathogenesis in a mouse model of urinary tract infection. Am J Physiol Renal Physiol 316(5):F814\u2013F822. https:\/\/doi.org\/10.1152\/ajprenal.00133.2018","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"409_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/02813430802535312","volume":"2","author":"L Bjerrum","year":"2009","unstructured":"Bjerrum L, Gahrn-Hansen B, Grinsted P (2009) Pivmecillinam versus sulfamethizole for short-term treatment of uncomplicated acute cystitis in general practice: a randomized controlled trial. Scand J Prim Health Care 2(1):6\u201311. https:\/\/doi.org\/10.1080\/02813430802535312","journal-title":"Scand J Prim Health Care"},{"key":"409_CR10","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1128\/AAC.00014-10","volume":"54","author":"MG Blango","year":"2010","unstructured":"Blango MG, Mulvey MA (2010) Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Agents Chemother 54:1855\u20131863. https:\/\/doi.org\/10.1128\/AAC.00014-10","journal-title":"Antimicrob Agents Chemother"},{"key":"409_CR11","unstructured":"Bonkat G, Pickard R, Bartoletti R, Cai T, Geerlings SE, K\u00f6ves B, Schubert S, Pilatz A, Veeratterapillay R, Wagenlehner F (2022) European Association of urology guidelines on urological infections. EAU Guidelines edn. Presented at the EAU annual congress Amsterdam, the Netherlands 2022. ISBN 978-94-92671-16-5. http:\/\/uroweb.org\/guideline\/urological-infections. Accessed 06 Apr 2022."},{"key":"409_CR12","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1515\/BC.2001.152","volume":"382","author":"K Brandenburg","year":"2001","unstructured":"Brandenburg K, J\u00fcrgens G, M\u00fcller M, Fukuoka S, Koch MHJ (2001) Biophysical characterization of lipopolysaccharide and lipid a inactivation by lactoferrin. Biol Chem 382:1215\u20131225. https:\/\/doi.org\/10.1515\/BC.2001.152","journal-title":"Biol Chem"},{"key":"409_CR13","doi-asserted-by":"publisher","first-page":"D641","DOI":"10.1093\/nar\/gkr989","volume":"40","author":"L Chen","year":"2012","unstructured":"Chen L, Xiong Z, Sun L, Yang J, Jin Q (2012) VFDB 2012 update: toward the genetic diversity and molecular evolution of bacterial virulence factors. Nucleic Acids Res 40:D641\u2013D645. https:\/\/doi.org\/10.1093\/nar\/gkr989","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"409_CR14","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1128\/CMR.00022-13","volume":"26","author":"MA Croxen","year":"2013","unstructured":"Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M, Finlay BB (2013) Recent advances in understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev 26(4):822\u2013880. https:\/\/doi.org\/10.1128\/CMR.00022-13","journal-title":"Clin Microbiol Rev"},{"key":"409_CR15","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3389\/fimmu.2017.00705","volume":"8","author":"A Cutone","year":"2017","unstructured":"Cutone A, Rosa L, Lepanto MS, Scotti MJ, Berlutti F, Bonaccorsi di Patti MC, Musci G, Valenti P (2017) Lactoferrin efficiently counteracts the inflammation-induced changes of the iron homeostasis system in macrophages. Front Immunol 8:705. https:\/\/doi.org\/10.3389\/fimmu.2017.00705","journal-title":"Front Immunol"},{"issue":"9","key":"409_CR16","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.3390\/ijms20092128","volume":"20","author":"A Cutone","year":"2019","unstructured":"Cutone A, Lepanto MS, Rosa L, Scotti MJ, Rossi A, Ranucci S, De Fino I, Bragonzi A, Valenti P, Musci G, Berlutti F (2019) Aerosolized bovine lactoferrin counteracts infection, inflammation and iron dysbalance in a cystic fibrosis mouse model of pseudomonas aeruginosa chronic lung infection. Int J Mol Sci 20(9):2128. https:\/\/doi.org\/10.3390\/ijms20092128","journal-title":"Int J Mol Sci"},{"key":"409_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/s0165-2427(03)00098-9","volume":"95","author":"MS Diarra","year":"2003","unstructured":"Diarra MS, Petitclerc D, Deschenes E, Lessard N, Grondin G, Talbot BG, Lacasse P (2003) Lactoferrin against Staphylococcus aureus mastitis. lactoferrin alone or in combination with penicillin G on bovine polymorphonuclear function and mammary epithelial cells colonisation by Staphylococcus aureus. Vet Immunol Immunopathol 95:33\u201342. https:\/\/doi.org\/10.1016\/s0165-2427(03)00098-9","journal-title":"Vet Immunol Immunopathol"},{"key":"409_CR18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1099\/jmm.0.05410-0","volume":"53","author":"AM Di Biase","year":"2004","unstructured":"Di Biase AM, Tinari A, Pietrantoni A, Antonini G, Valenti P, Conte MP, Superti F (2004) Effect of bovine lactoferricin on enteropathogenic Yersinia adhesion and invasion in HEp-2 cells. J Med Microbiol 53:407\u2013412. https:\/\/doi.org\/10.1099\/jmm.0.05410-0","journal-title":"J Med Microbiol"},{"key":"409_CR19","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1128\/IAI.70.4.1860-1866.2002","volume":"70","author":"E Elass","year":"2002","unstructured":"Elass E, Masson M, Mazurier J, Legrand D (2002) Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycan binding ability of interleukin-8 in human endothelial cells. Infect Immun 70:1860\u20131866. https:\/\/doi.org\/10.1128\/IAI.70.4.1860-1866.2002","journal-title":"Infect Immun"},{"key":"409_CR20","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.2903\/j.efsa.2012.2701","volume":"10","author":"European Food Safety Authority","year":"2012","unstructured":"European Food Safety Authority (2012) Scientific opinion on bovine lactoferrin. EFSA J 10:2701. https:\/\/doi.org\/10.2903\/j.efsa.2012.2701","journal-title":"EFSA J"},{"key":"409_CR21","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","volume":"13","author":"AL Flores-Mireles","year":"2015","unstructured":"Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ (2015) Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 13:269\u2013284. https:\/\/doi.org\/10.1038\/nrmicro3432","journal-title":"Nat Rev Microbiol"},{"key":"409_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1067\/mda.2003.7","volume":"49","author":"B Foxman","year":"2003","unstructured":"Foxman B (2003) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 49:53\u201370. https:\/\/doi.org\/10.1067\/mda.2003.7","journal-title":"Dis Mon"},{"key":"409_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.idc.2013.09.003","volume":"28","author":"B Foxman","year":"2014","unstructured":"Foxman B (2014) Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am 28:1\u201313. https:\/\/doi.org\/10.1016\/j.idc.2013.09.003","journal-title":"Infect Dis Clin North Am"},{"issue":"5","key":"409_CR24","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s10534-014-9740-9","volume":"27","author":"A Frioni","year":"2014","unstructured":"Frioni A, Conte MP, Cutone A, Longhi C, Musci G, di Patti MC, Natalizi T, Marazzato M, Lepanto MS, Puddu P, Paesano R et al (2014) Lactoferrin differently modulates the inflammatory response in epithelial models mimicking human inflammatory and infectious diseases. Biometals 27(5):843\u2013856. https:\/\/doi.org\/10.1007\/s10534-014-9740-9","journal-title":"Biometals"},{"key":"409_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2217\/fmb-2016-0145","volume":"12","author":"A Guglietta","year":"2017","unstructured":"Guglietta A (2017) Recurrent urinary tract infections in women: risk factors, etiology, pathogenesis and prophylaxis. Future Microbiol 12:239\u2013246. https:\/\/doi.org\/10.2217\/fmb-2016-0145","journal-title":"Future Microbiol"},{"issue":"1","key":"409_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.7326\/0003-4819-135-1-200107030-00012","volume":"135","author":"K Gupta","year":"2001","unstructured":"Gupta K, Hooton TM, Stamm WE (2001) Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 135(1):41\u201350. https:\/\/doi.org\/10.7326\/0003-4819-135-1-200107030-00012","journal-title":"Ann Intern Med"},{"issue":"8","key":"409_CR27","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1021\/jm300165m","volume":"55","author":"Z Han","year":"2012","unstructured":"Han Z, Pinkner JS, Ford B, Chorell E, Crowley JM, Cusumano CK, Campbell S, Henderson JP, Hultgren SJ, Janetka JW (2012) Lead optimization studies on FimH antagonists: discovery of potent and orally bioavailable ortho-substituted biphenyl mannosides. J Med Chem 55(8):3945\u20133959. https:\/\/doi.org\/10.1021\/jm300165m","journal-title":"J Med Chem"},{"key":"409_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0924-8579(94)90038-8","volume":"4","author":"GK Harding","year":"1994","unstructured":"Harding GK, Ronald AR (1994) The management of urinary infections: what have we learned in the past decade? Int J Antimicrob Agents 4:83\u201388. https:\/\/doi.org\/10.1016\/0924-8579(94)90038-8","journal-title":"Int J Antimicrob Agents"},{"key":"409_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3909\/riu0566","volume":"15","author":"DR Hickling","year":"2013","unstructured":"Hickling DR, Nitti VW (2013) Management of recurrent urinary tract infections in healthy adult women. Rev Urol 15:41\u201348. https:\/\/doi.org\/10.3909\/riu0566","journal-title":"Rev Urol"},{"issue":"1","key":"409_CR30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/22221751.2021.1888660","volume":"10","author":"Y Hu","year":"2021","unstructured":"Hu Y, Meng X, Zhang F, Xiang Y, Wang J (2021) The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor. Emerg Microbes Infect 10(1):317\u2013330. https:\/\/doi.org\/10.1080\/22221751.2021.1888660","journal-title":"Emerg Microbes Infect"},{"key":"409_CR31","doi-asserted-by":"publisher","first-page":"CD001321","DOI":"10.1002\/14651858.CD001321.pub5","volume":"10","author":"RG Jepson","year":"2012","unstructured":"Jepson RG, Williams G, Craig JC (2012) Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 10:CD001321. https:\/\/doi.org\/10.1002\/14651858.CD001321.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"409_CR32","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1128\/CMR.4.1.80","volume":"4","author":"JR Johnson","year":"1991","unstructured":"Johnson JR (1991) Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 4:80\u2013128. https:\/\/doi.org\/10.1128\/CMR.4.1.80","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"409_CR33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1067\/mlc.2002.121550","volume":"139","author":"JR Johnson","year":"2002","unstructured":"Johnson JR, Russo TA (2002) Extraintestinal pathogenic Escherichia coli: \u201cthe other bad E. coli\". J Lab Clin Med 139(3):155\u2013162. https:\/\/doi.org\/10.1067\/mlc.2002.121550","journal-title":"J Lab Clin Med"},{"issue":"1","key":"409_CR34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1056\/nejmcp1702758","volume":"378","author":"JR Johnson","year":"2018","unstructured":"Johnson JR, Russo TA (2018) Acute pyelonephritis in adults. N Engl J Med 378(1):48\u201359. https:\/\/doi.org\/10.1056\/nejmcp1702758","journal-title":"N Engl J Med"},{"key":"409_CR35","doi-asserted-by":"publisher","first-page":"562525","DOI":"10.3389\/fcimb.2021.562525","volume":"11","author":"J Josephs-Spaulding","year":"2021","unstructured":"Josephs-Spaulding J, Krogh TJ, Rettig HC, Lyng M, Chkonia M, Waschina S, Graspeuntner S, Rupp J, M\u00f8ller-Jensen J, Kaleta C (2021) Recurrent urinary tract infections: unraveling the complicated environment of uncomplicated rUTIs. Front Cell Infect Microbiol 11:562525. https:\/\/doi.org\/10.3389\/fcimb.2021.562525","journal-title":"Front Cell Infect Microbiol"},{"issue":"18","key":"409_CR36","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1001\/jama.2016.16141","volume":"316","author":"M Juthani-Mehta","year":"2016","unstructured":"Juthani-Mehta M, Van Ness PH, Bianco L, Rink A, Rubeck S, Ginter S, Argraves S, Charpentier P, Acampora D, Trentalange M, Quagliarello V, Peduzzi P (2016) Effect of cranberry capsules on bacteriuria plus pyuria among older women in nursing homes: a randomized clinical trial. JAMA 316(18):1879\u20131887. https:\/\/doi.org\/10.1001\/jama.2016.16141","journal-title":"JAMA"},{"key":"409_CR37","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1271\/bbb.64.348","volume":"64","author":"Y Kawasaki","year":"2000","unstructured":"Kawasaki Y, Tazume S, Shimizu K, Matsuzawa H, Dosako S, Isoda H, Tsukiji M, Fujimura R, Muranaka Y, Isihida H (2000) Inhibitory effects of bovine lactoferrin on the adherence of enterotoxigenic Escherichia Coli to host cells. Biosci Biotech Biochem 64:348\u2013354. https:\/\/doi.org\/10.1271\/bbb.64.348","journal-title":"Biosci Biotech Biochem"},{"key":"409_CR38","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.febslet.2011.12.011","volume":"586","author":"CW Kim","year":"2012","unstructured":"Kim CW, Lee TH, Park KH, Choi SY, Kim J (2012) Human lactoferrin suppresses TNF-\u03b1-induced intercellular adhesion molecule-1 expression via competition with NF-kB in endothelial cells. FEBS Lett 586:229\u2013234. https:\/\/doi.org\/10.1016\/j.febslet.2011.12.011","journal-title":"FEBS Lett"},{"key":"409_CR39","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4274\/Mirt.80664","volume":"22","author":"FS K\u0131ra\u00e7","year":"2013","unstructured":"K\u0131ra\u00e7 FS (2013) Is ethics approval necessary for all trials? A clear but not certain process. Mol Imaging Radionucl Ther 22:73\u201375. https:\/\/doi.org\/10.4274\/Mirt.80664","journal-title":"Mol Imaging Radionucl Ther"},{"key":"409_CR40","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.ijmm.2011.09.006","volume":"301","author":"CD K\u04e7hler","year":"2011","unstructured":"K\u04e7hler CD, Dobrindt U (2011) What defines extraintestinal pathogenic Escherichia coli? Int J Med Microbiol 301:642\u2013647. https:\/\/doi.org\/10.1016\/j.ijmm.2011.09.006","journal-title":"Int J Med Microbiol"},{"issue":"2","key":"409_CR41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.pop.2019.01.001","volume":"46","author":"KB Kolman","year":"2019","unstructured":"Kolman KB (2019) Cystitis and pyelonephritis: diagnosis, treatment, and prevention. Prim Care 46(2):191\u2013202. https:\/\/doi.org\/10.1016\/j.pop.2019.01.001","journal-title":"Prim Care"},{"key":"409_CR42","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.3389\/fimmu.2018.02123","volume":"9","author":"MS Lepanto","year":"2018","unstructured":"Lepanto MS, Rosa L, Cutone A, Conte MP, Paesano R, Valenti P (2018) Efficacy of lactoferrin oral administration in the treatment of anemia and anemia of inflammation in pregnant and non-pregnant women: an interventional study. Front Immunol 9:2123. https:\/\/doi.org\/10.3389\/fimmu.2018.02123","journal-title":"Front Immunol"},{"key":"409_CR43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/molecules24071323","volume":"3","author":"MS Lepanto","year":"2019","unstructured":"Lepanto MS, Rosa L, Paesano R, Valenti P, Cutone A (2019a) Lactoferrin in aseptic and septic inflammation. Molecules 3:24. https:\/\/doi.org\/10.3390\/molecules24071323","journal-title":"Molecules"},{"issue":"22","key":"409_CR44","doi-asserted-by":"publisher","first-page":"5666","DOI":"10.3390\/ijms20225666","volume":"20","author":"MS Lepanto","year":"2019","unstructured":"Lepanto MS, Rosa L, Cutone A, Scotti MJ, Conte AL, Marazzato M, Zagaglia C, Longhi C, Berlutti F, Musci G, Valenti P, Conte MP (2019b) Bovine lactoferrin pre-treatment induces intracellular killing of AIEC LF82 and reduces bacteria-induced DNA damage in differentiated human enterocytes. Int J Mol Sci 20(22):5666. https:\/\/doi.org\/10.3390\/ijms20225666","journal-title":"Int J Mol Sci"},{"issue":"1","key":"409_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/BF00195948","volume":"182","author":"C Longhi","year":"1993","unstructured":"Longhi C, Conte MP, Seganti L, Polidoro M, Alfsen A, Valenti P (1993) Influence of lactoferrin on the entry process of Escherichia Coli HB101(PRI203) in HeLa cells. Med Microbiol Immunol 182(1):25\u201335. https:\/\/doi.org\/10.1007\/BF00195948","journal-title":"Med Microbiol Immunol"},{"issue":"12","key":"409_CR46","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1002\/cbic.202100016","volume":"22","author":"J Lu","year":"2021","unstructured":"Lu J, Francis JD, Guevara MA, Moore RE, Chambers SA, Doster RS, Eastman AJ, Rogers LM, Noble KN, Manning SD, Damo SM, Aronoff DM, Townsend SD, Gaddy JA (2021) Antibacterial and anti-biofilm activity of the human breast milk glycoprotein lactoferrin against group B Streptococcus. ChemBioChem 22(12):2124\u20132133. https:\/\/doi.org\/10.1002\/cbic.202100016","journal-title":"ChemBioChem"},{"key":"409_CR47","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2147\/IJGM.S11767","volume":"4","author":"D Minardi","year":"2011","unstructured":"Minardi D, d\u2019Anzeo G, Cantoro D, Conti A, Muzzonigro G (2011) Urinary tract infections in women: etiology and treatment options. Int J Gen Med 4:333\u2013343. https:\/\/doi.org\/10.2147\/IJGM.S11767","journal-title":"Int J Gen Med"},{"key":"409_CR48","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1086\/427507","volume":"40","author":"LE Nicolle","year":"2005","unstructured":"Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM, Infectious Diseases Society of America, American Society of Nephrology, American Geriatric Society (2005) Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 40:643\u2013654. https:\/\/doi.org\/10.1086\/427507","journal-title":"Clin Infect Dis"},{"key":"409_CR49","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/QCO.0000000000000130","volume":"28","author":"VP O\u2019Brien","year":"2015","unstructured":"O\u2019Brien VP, Hannan TJ, Schaeffer AJ, Hultgren SJ (2015) Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection. Curr Opin Infect Dis 28:97\u2013105. https:\/\/doi.org\/10.1097\/QCO.0000000000000130","journal-title":"Curr Opin Infect Dis"},{"key":"409_CR50","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.UTI-0013-2012","author":"VP O\u2019Brien","year":"2016","unstructured":"O\u2019Brien VP, Hannan TJ, Nielsen HV, Hultgren SJ (2016) Drug and vaccine development for the treatment and prevention of urinary tract infections. Microbiol Spectr. https:\/\/doi.org\/10.1128\/microbiolspec.UTI-0013-2012","journal-title":"Microbiol Spectr"},{"key":"409_CR51","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1179\/2047773212Y.0000000043","volume":"106","author":"R Paesano","year":"2012","unstructured":"Paesano R, Natalizi T, Berlutti F, Valenti P (2012) Body iron delocalization: the serious drawback in iron disorders in both developing and developed countries. Pathog Glob Health 106:200\u2013216. https:\/\/doi.org\/10.1179\/2047773212Y.0000000043","journal-title":"Pathog Glob Health"},{"issue":"6","key":"409_CR52","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1159\/000499342","volume":"11","author":"KA Patras","year":"2019","unstructured":"Patras KA, Ha AD, Rooholfada E, Olson J, Ramachandra Rao SP, Lin AE, Nizet V (2019) Augmentation of urinary lactoferrin enhances host innate immune clearance of uropathogenic Escherichia coli. J Innate Immun 11(6):481\u2013495. https:\/\/doi.org\/10.1159\/000499342","journal-title":"J Innate Immun"},{"key":"409_CR53","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1002\/nau.23173","volume":"36","author":"V Ph\u00e9","year":"2017","unstructured":"Ph\u00e9 V, Pakzad M, Haslam C, Gonzales G, Curtis C, Porter B, Chataway J, Panicker JN (2017) Open label feasibility study evaluating D-mannose combined with home-based monitoring of suspected urinary tract infections in patients with multiple sclerosis. Neurourol Urodyn 36:1770\u20131775. https:\/\/doi.org\/10.1002\/nau.23173","journal-title":"Neurourol Urodyn"},{"key":"409_CR54","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.3390\/ijms18091985","volume":"18","author":"L Rosa","year":"2017","unstructured":"Rosa L, Cutone A, Lepanto MS, Paesano R, Valenti P (2017) Lactoferrin: a natural glycoprotein involved in iron and inflammatory homeostasis. Int J Mol Sci 18:1985. https:\/\/doi.org\/10.3390\/ijms18091985","journal-title":"Int J Mol Sci"},{"issue":"2\u20133","key":"409_CR55","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10534-020-00236-2","volume":"33","author":"L Rosa","year":"2020","unstructured":"Rosa L, Lepanto MS, Cutone A, Siciliano RA, Paesano R, Costi R, Musci G, Valenti P (2020) Influence of oral administration mode on the efficacy of commercial bovine Lactoferrin against iron and inflammatory homeostasis disorders. Biometals 33(2\u20133):159\u2013168. https:\/\/doi.org\/10.1007\/s10534-020-00236-2","journal-title":"Biometals"},{"key":"409_CR56","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1139\/o01-209","volume":"80","author":"P Rossi","year":"2002","unstructured":"Rossi P, Giansanti F, Boffi A, Ajello M, Valenti P, Chiancone E, Antonini G (2002) Ca2+ binding to bovine lactoferrin enhances protein stability and influences the release of bacterial lipopolysaccharide. Biochem Cell Biol 80:41\u201348. https:\/\/doi.org\/10.1139\/o01-209","journal-title":"Biochem Cell Biol"},{"key":"409_CR57","doi-asserted-by":"publisher","first-page":"20","DOI":"10.7326\/0003-4819-142-1-200501040-00008","volume":"142","author":"D Scholes","year":"2005","unstructured":"Scholes D, Hooton TM, Roberts PL, Gupta K, Stapleton AE, Stamm WE (2005) Risk factors associated with acute pyelonephritis in healthy women. Ann Intern Med 142:20\u201327. https:\/\/doi.org\/10.7326\/0003-4819-142-1-200501040-00008","journal-title":"Ann Intern Med"},{"key":"409_CR58","first-page":"801","volume":"07","author":"A Sen","year":"2008","unstructured":"Sen A (2008) Recurrent cystitis in non-pregnant women. BMJ Clin Evid 07:801","journal-title":"BMJ Clin Evid"},{"issue":"1","key":"409_CR59","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1139\/bcb-2016-0049","volume":"95","author":"R Sessa","year":"2017","unstructured":"Sessa R, Di Pietro M, Filardo S, Bressan A, Rosa L, Cutone A, Frioni A, Berlutti F, Paesano R, Valenti P (2017) Effect of bovine lactoferrin on Chlamydia trachomatis infection and inflammation. Biochem Cell Biol 95(1):34\u201340. https:\/\/doi.org\/10.1139\/bcb-2016-0049","journal-title":"Biochem Cell Biol"},{"issue":"6888","key":"409_CR60","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/417552a","volume":"417","author":"PK Singh","year":"2002","unstructured":"Singh PK, Parsek MR, Greenberg EP, Welsh MJ (2002) A component of innate immunity prevents bacterial biofilm development. Nature 417(6888):552\u2013555. https:\/\/doi.org\/10.1038\/417552a","journal-title":"Nature"},{"key":"409_CR61","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.juro.2006.08.081","volume":"177","author":"SM Soto","year":"2007","unstructured":"Soto SM, Smithson A, Martinez JA, Horcajada JP, Mensa J, Vila J (2007) Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulence factors and anti-microbial resistance. J Urol 177:365\u2013368. https:\/\/doi.org\/10.1016\/j.juro.2006.08.081","journal-title":"J Urol"},{"issue":"6","key":"409_CR62","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1039\/c4mt00329b","volume":"7","author":"S Subashchandrabose","year":"2015","unstructured":"Subashchandrabose S, Mobley HL (2015) Back to the metal age: battle for metals at the host-pathogen interface during urinary tract infection. Metallomics 7(6):935\u2013942. https:\/\/doi.org\/10.1039\/c4mt00329b","journal-title":"Metallomics"},{"key":"409_CR63","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1007\/s00018-005-5371-1","volume":"62","author":"YA Suzuki","year":"2005","unstructured":"Suzuki YA, Lopez V, L\u00f6nnerdal B (2005) Mammalian lactoferrin receptors: Structure and function. Cell Mol Life Sci 62:2560\u20132575. https:\/\/doi.org\/10.1007\/s00018-005-5371-1","journal-title":"Cell Mol Life Sci"},{"key":"409_CR64","doi-asserted-by":"publisher","first-page":"10915","DOI":"10.1021\/bi8012164","volume":"47","author":"YA Suzuki","year":"2008","unstructured":"Suzuki YA, Wong H, Ashida KY, Schryvers AB, Lo\u00f6nnerdal B (2008) The N1 domain of human lactoferrin is required for internalization by caco-2 cells and targeting to the nucleus. Biochemistry 47:10915\u201310920. https:\/\/doi.org\/10.1021\/bi8012164","journal-title":"Biochemistry"},{"key":"409_CR65","unstructured":"U.S. FDA (2014) GRN 000465 cow\u2019s milk-derived lactoferrin; Morinaga Milk Industry Co., Ltd.: Tokyo, Japan; U.S. Food and Drug Administration (U.S. FDA), Center for Food Safety & Applied Nutrition (CFSAN), Office of Food Additive Safety: Silver Spring, MD, USA. http:\/\/www.accessdata.fda.gov\/scripts\/fdcc\/index.cfm?set=GRASNotices&id=465. Accessed 06 Apr 2022."},{"key":"409_CR66","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1007\/s00018-005-5372-0","volume":"62","author":"P Valenti","year":"2005","unstructured":"Valenti P, Antonini G (2005) Lactoferrin: an important host defence against microbial and viral attack. Cell Mol Life Sci 62:2576\u20132587. https:\/\/doi.org\/10.1007\/s00018-005-5372-0","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"409_CR67","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1139\/bcb-2016-0050","volume":"95","author":"P Valenti","year":"2017","unstructured":"Valenti P, Frioni A, Rossi A, Ranucci S, De Fino I, Cutone A, Rosa L, Bragonzi A, Berlutti F (2017) Aerosolized bovine lactoferrin reduces neutrophils and pro-inflammatory cytokines in mouse models of Pseudomonas aeruginosa lung infections. Biochem Cell Biol 95(1):41\u201347. https:\/\/doi.org\/10.1139\/bcb-2016-0050","journal-title":"Biochem Cell Biol"},{"key":"409_CR68","doi-asserted-by":"publisher","first-page":"4707","DOI":"10.3390\/ijms20194707","volume":"20","author":"A Vega-Bautista","year":"2019","unstructured":"Vega-Bautista A, de la Garza M, Carrero JC, Campos-Rodr\u00edguez R, God\u00ednez-Victoria M, Drago-Serrano ME (2019) The impact of lactoferrin on the growth of intestinal inhabitant bacteria. Int J Mol Sci 20:4707. https:\/\/doi.org\/10.3390\/ijms20194707","journal-title":"Int J Mol Sci"},{"key":"409_CR69","unstructured":"WHO Regional Office for Europe\/European Centre for Disease Prevention and Control (2022) Antimicrobial resistance surveillance in Europe 2022\u20132020 data. Copenhagen: WHO Regional Office for Europe. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/antimicrobial-resistance-surveillance-europe-2022-2020-data. Accessed 06 Apr 2022"}],"container-title":["BioMetals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10534-022-00409-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10534-022-00409-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10534-022-00409-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T10:25:37Z","timestamp":1683887137000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10534-022-00409-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["409"],"URL":"https:\/\/doi.org\/10.1007\/s10534-022-00409-1","relation":{},"ISSN":["0966-0844","1572-8773"],"issn-type":[{"type":"print","value":"0966-0844"},{"type":"electronic","value":"1572-8773"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"assertion":[{"value":"8 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}